MARCENARO, EMANUELA
 Distribuzione geografica
Continente #
EU - Europa 14.484
Totale 14.484
Nazione #
IT - Italia 14.484
Totale 14.484
Città #
Genova 11.514
Rapallo 1.653
Genoa 1.266
Bordighera 51
Totale 14.484
Nome #
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 163
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 159
NK/DC crosstalk in anti-viral response. 153
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 149
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 147
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 146
Markers and function of human NK cells in normal and pathological conditions 141
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 140
NK cells and their receptors during viral infections. 137
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 136
2B4 functions as a co-receptor in human NK cell activation 135
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. 133
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 133
Role of the 2B4 receptor in CD8+ T-cell-dependent immune control of Epstein-Barr virus infection in mice with reconstituted human immune system components 132
Bridging innate NK cell Functions with Adaptive Immunity. 129
Multi-directional cross-regulation of NK cell function during innate immune responses. 128
Features of Memory-Like and PD-1+ Human NK Cell Subsets 126
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 124
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 124
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 124
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 124
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 123
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 121
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 121
Pathogen-induced private conversations between natural killer and dendritic cells 120
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation 119
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 118
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 118
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 118
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. 116
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 116
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues 113
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 113
Natural killer lymphocytes: "null cells" no more. 113
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 113
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy 112
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 112
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 111
Identification of NKG2A and NKp80 as specific Natural Killer cell markers in rhesus and pigtailed monkeys 111
Harnessing NK Cells for Cancer Treatment 111
Human NK cell response to pathogens 110
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 109
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 108
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 107
Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways 107
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 106
Natural killer cell-triggering receptors in patients with acute leukaemia. 105
Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis 105
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 104
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 104
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 103
Human Natural Killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection 102
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 102
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 102
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 101
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 101
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 100
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 100
TLR/NCR/KIR: Which One to Use and When? 100
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis 100
NK cells: innate immunity against hematological malignancies? 100
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 99
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 99
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 98
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 98
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer cell subsets associated with high levels of HIV-1 viremia. 97
NK-DC interaction: On the usefulness of auto-aggression 97
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. 97
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 97
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 95
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 95
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML 95
Natural killer cells in HIV-Infectious: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. 94
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection 94
It's only innate immunity but I like it 94
Human NK cells directly recognize Mycobacterium Bovis and acquire the ability to interact with monocyte-derived DC 93
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma 93
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. 91
The NK/DC complot 90
Monoclonal Antibodies against NKG2A 89
Cognate HLA absence in trans diminishes human NK cell education 89
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 89
Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. 87
Monoclonal Antibodies against NKG2A 86
Editorial: NK Cell Subsets in Health and Disease: New Developments 86
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 86
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 84
Receptor-mediated regulation of human NK cells homing 84
Monoclonal Antibodies against NKG2A 83
The Chem23 receptor for chemerin is expressed in CD56dim, CD16neg NK human cells 83
Monoclonal Antibodies against NKG2A 81
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. 81
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 79
Dysregulation of regulatory CD56 (bright) NK cells/T cells interactions in multiple sclerosis 79
Monoclonal Antibodies against NKG2A 78
NK cells at the interface between innate and adaptive immunity 78
Human NK cells directly recognize Mycobacterium bovis and acquire the ability to interact with monocyte-derived DC 78
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 78
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 77
NK CELLS IN INNATE AND ADAPTIVE IMMUNITY 76
Totale 10.705
Categoria #
all - tutte 41.823
article - articoli 33.091
book - libri 306
conference - conferenze 4.191
curatela - curatele 0
other - altro 250
patent - brevetti 2.699
selected - selezionate 0
volume - volumi 1.286
Totale 83.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019622 0 0 0 0 0 0 0 0 0 0 337 285
2019/20204.130 155 87 148 269 340 468 655 285 409 726 456 132
2020/20211.405 96 114 80 96 53 233 44 113 119 217 105 135
2021/20222.122 77 160 151 183 116 118 142 495 156 186 95 243
2022/20232.047 238 154 23 194 297 348 4 178 381 21 178 31
2023/2024961 63 177 34 136 93 122 80 125 69 48 14 0
Totale 14.954